These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Treatment of patients with angina pectoris in general practice with a new transdermal therapeutic system containing nitroglycerin (author's transl)]. Garnier B; Imhof P; Spinelli F; Jost H Schweiz Rundsch Med Prax; 1982 Mar; 71(12):511-6. PubMed ID: 6806799 [No Abstract] [Full Text] [Related]
44. Nitroglycerin ointment for angina pectoris. Med Lett Drugs Ther; 1981 Sep; 23(19):82-3. PubMed ID: 6792478 [No Abstract] [Full Text] [Related]
45. Management of chronic stable angina pectoris. Rodríguez-Ospina L; Montano-Soto L Bol Asoc Med P R; 2008; 100(4):39-47. PubMed ID: 19400528 [TBL] [Abstract][Full Text] [Related]
46. [Comparative efficacy, safety, cardio-hemodynamic effects of isosorbide dinitrate (ID) aerosol and sublingual tablets of nitroglycerin]. Ol'binskaia LI; Sizova ZhM; Ushakova AV Ter Arkh; 1998; 70(5):69-72. PubMed ID: 9644750 [TBL] [Abstract][Full Text] [Related]
47. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina]. Cianfrocca C; Sabia R; Zoboli S; Bugiardini R G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869 [TBL] [Abstract][Full Text] [Related]
48. [A trial of the use of the transdermal preparation Deponit for treating stenocardia]. Alliluev IG; Pecherskaia MB; Poltavskaia MG; Syrkin AL Ter Arkh; 1996; 68(6):55-8. PubMed ID: 8771688 [No Abstract] [Full Text] [Related]
49. [Frequency of sublingual nitroglycerin prescription in patients with coronary artery disease and angina and awareness of patients about the shelf life of the drug]. Yılmaz OC; Keskin G; Cuğlan B; Selçoki Y; Temizkan A; Eryonucu B; Soran O Turk Kardiyol Dern Ars; 2011 Sep; 39(6):469-73. PubMed ID: 21918316 [TBL] [Abstract][Full Text] [Related]
50. [Severe bradycardia and arterial hypotension following the administration of sublingual nitroglycerin]. Sanz Girgas E; Tornos MP; Permanyer Miralda G; Carner X; Soler Soler J Rev Esp Cardiol; 1990; 43(6):403-5. PubMed ID: 2122504 [TBL] [Abstract][Full Text] [Related]
51. A multicenter comparison of adhesion, preference, tolerability, and safety characteristics of two transdermal nitroglycerin delivery systems: Transderm-Nitro and Deponit. Chinoy DA; Camp J; Elchahal S; Godoy C; Grossman W; Hai H; Hamilton W; Kushner M; McGreevy M; Mulvihill RJ Clin Ther; 1989; 11(5):678-84. PubMed ID: 2509071 [TBL] [Abstract][Full Text] [Related]
53. [Long-term effect of organic nitrates in angina pectoris: dependence on the form of administration and mode of stress]. Schneider W; Bussmann WD; Kober G; Kaltenbach M Z Kardiol; 1989; 78 Suppl 2():83-7; discussion 115-7. PubMed ID: 2531510 [TBL] [Abstract][Full Text] [Related]
54. The long-term safety and tolerability of transdermal glyceryl trinitrate, when used with a patch-free interval in patients with stable angina. Wainwright RJ; Foran JP; Padaria SF; Akhras F; Jackson G; Clark AR Br J Clin Pract; 1993; 47(4):178-82. PubMed ID: 8260332 [TBL] [Abstract][Full Text] [Related]
55. How best to use nitrates. Desilvio A; Barlattani MP Br Med J (Clin Res Ed); 1987 Nov; 295(6607):1163-4. PubMed ID: 3120926 [No Abstract] [Full Text] [Related]
56. Letter: Development of a stable sublingual nitroglycerin tablet I: interaction of nitroglycerin with selected macromolecules. Fung HL; Yap SK; Rhodes CT J Pharm Sci; 1974 Nov; 63(11):1810-2. PubMed ID: 4214916 [No Abstract] [Full Text] [Related]
57. Symptomatic bradycardia following the administration of sublingual nitroglycerin. Buckley R; Roberts R Am J Emerg Med; 1993 May; 11(3):253-5. PubMed ID: 8489673 [TBL] [Abstract][Full Text] [Related]